« Alle Studien

ASTRAL-3 Studie

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection

Literaturstellen

Im Arzneimittelbrief